Premium
[P4–014]: THE COALITION AGAINST MAJOR DISEASES: TOWARD U.S. FDA QUALIFICATION OF HIPPOCAMPAL VOLUME AS A BIOMARKER FOR ENRICHMENT IN CLINICAL TRIALS FOR PRE‐DEMENTIA STAGES OF ALZHEIMER'S DISEASE
Author(s) -
Conrado Daniela J.,
Romero Klaus,
Corrigan Brian,
Ito Kaori,
Nicholas Timothy,
Chen Danny,
Samtani Mahesh N.,
Stone Julie,
Sinha Vikram,
Willis Brian A.,
Kern Volker D.,
Hill Derek L.,
Cole Patricia E.,
Novak Gerald P.,
Meibach Richard,
Matthews Dawn C.,
Schwarz Adam J.,
Xie Zhiyong,
Gordon Mark Forrest,
Arneric Stephen P.
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.1878
Subject(s) - dementia , alzheimer's disease neuroimaging initiative , biomarker , clinical trial , medicine , neuroimaging , context (archaeology) , clinical dementia rating , disease , imaging biomarker , oncology , alzheimer's disease , magnetic resonance imaging , psychiatry , radiology , paleontology , biochemistry , chemistry , biology
P4-014 THE COALITION AGAINST MAJOR DISEASES: TOWARD U.S. FDA QUALIFICATION OF HIPPOCAMPAL VOLUME AS A BIOMARKER FOR ENRICHMENT IN CLINICALTRIALS FOR PRE-DEMENTIA STAGES OF ALZHEIMER’S DISEASE Daniela J. Conrado, Klaus Romero, Brian Corrigan, Kaori Ito, Timothy Nicholas, Danny Chen, Mahesh N. Samtani, Julie Stone, Vikram Sinha, Brian A. Willis, Volker D. Kern, Derek L. Hill, Patricia E. Cole, Gerald P. Novak, Richard Meibach, Dawn C. Matthews, Adam J. Schwarz, Zhiyong Xie, Mark Forrest Gordon, Stephen P. Arneric, Critical Path Institute, Tucson, AZ, USA; Pfizer Inc, Groton, CT, USA; Pfizer Early Clinical Development, Cambridge, MA, USA; Johnson & Johnson, New Brunswick, NJ, USA; Merck & Co Inc, Kenilworth, NJ, USA; Eli Lilly and Company, Indianapolis, IN, USA; IXICO, London, United Kingdom; Takeda Pharmaceuticals International, Deerfield, IL, USA; Novartis Pharmaceuticals, Florham Park, NJ, USA; ADM Diagnostics, Northbrook, IL, USA; Advisor, New York, NY, USA. Contact e-mail: DConrado@c-path.org